27 assets in Multiple System Atrophy

Therapeutic assets addressing Multiple System Atrophy, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Droxidopa Multiple System Atrophy	Loma Linda University	P3	BB (68)
Ath-434 Multiple System Atrophy	Alterity Therapeutics	P2	B (62)
Exidavnemab Multiple System Atrophy	BioArctic AB	P2	CCC (53)
Carbidopa Multiple System Atrophy	Daniel Claassen	P1/2	CCC (52)
Entacapone Multiple System Atrophy	Daniel Claassen	P1/2	CCC (52)
Midodrine Multiple System Atrophy	Vanderbilt University Medical Center	P1	CCC (52)
[18f]ucb-2897 Multiple System Atrophy	Invicro	P1	CC (47)
Trimetaphan Multiple System Atrophy	Vanderbilt University	P1	CC (46)
ub-312 Multiple System Atrophy	NYU Langone Health	P1	CC (46)
FDOPA Multiple System Atrophy	Daniel Claassen	P1	CC (43)
Huc-Msc-Sev-001 Nasal Drops Multiple System Atrophy	Xuanwu Hospital, Beijing	P1	CC (43)
PBR-06 Multiple System Atrophy	Brigham and Women's Hospital	Early P1	CC (43)
sst001 Multiple System Atrophy	Synusight Biotech (Shanghai) Co., Ltd.	P1	CC (43)
[11c]modag-005 Multiple System Atrophy	MODAG GmbH	Early P1	C (39)
[18F]ACI-15916 Multiple System Atrophy	AC Immune SA	Early P1	C (39)
[18F]MODAG-009 Multiple System Atrophy	MODAG GmbH	Early P1	C (39)
C11-SY08 Multiple System Atrophy	Massachusetts General Hospital	Early P1	C (39)
Fludeoxyglucose Multiple System Atrophy	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
mk-6240 Multiple System Atrophy	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
PE 2I Multiple System Atrophy	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)
SDM-8 Multiple System Atrophy	Universitaire Ziekenhuizen KU Leuven	N/A	D (30)